Investor Overview

Merus discovers and develops differentiated therapeutics aimed at substantially prolonging the lives of cancer patients. It is our strategy to use the power of bispecific antibody engineering and advanced screening technologies to develop biopharmaceuticals that engage the power of the immune system to kill tumor cells.

Summary Share Price

NASDAQ: MRUS0.0017.82
Data provided by Nasdaq. Minimum 15 minutes delayed.

Upcoming Events

Thursday, February 22, 2018
 11:00 a.m. ET
RBC Capital Markets 2018 Global Healthcare Conference

Corporate Presentation

February Investor Presentation - PDF February Investor Presentation